{
    "organizations": [],
    "uuid": "e97873110e2a0a63d57217d79a6474f24e899bf9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sarepta-therapeutics-reports-q4-no/brief-sarepta-therapeutics-reports-q4-non-gaap-loss-per-share-0-28-idUSASB0C8FV",
    "ord_in_thread": 0,
    "title": "BRIEF-Sarepta Therapeutics Reports Q4 Non-GAAP Loss Per Share $0.28",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Sarepta Therapeutics Inc:\n* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER 2017 AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS\n* Q4 NON-GAAP LOSS PER SHARE $0.28\n* Q4 GAAP LOSS PER SHARE $0.37 * Q4 REVENUE $57.3 MILLION * Q4 EARNINGS PER SHARE VIEW $-0.32, REVENUE VIEW $56.5 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-02T05:07:00.000+02:00",
    "crawled": "2018-03-01T23:23:16.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "sarepta",
        "therapeutic",
        "inc",
        "sarepta",
        "therapeutic",
        "announces",
        "fourth",
        "quarter",
        "financial",
        "result",
        "recent",
        "corporate",
        "development",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "gaap",
        "loss",
        "per",
        "share",
        "q4",
        "revenue",
        "million",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}